Ischemic injury enhances dendritic cell immunogenicity via TLR4 and NF-κB activation

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 2939-2948

  Jurewicz, Mollie ^a,b   Takakura, Ayumi ^a   Augello, Andrea ^a,b   Naini, Said Movahedi ^a   Ichimura, Takaharu ^a   Zandi Nejad, Kambiz ^a   Abdi, Reza ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; LIGAND; MINERAL OIL; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL LIGATION; FOOT PAD; IMMUNOGENICITY; IN VITRO STUDY; ISCHEMIA; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COCULTURE; DRUG EFFECT; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE; TRANSPLANTATION; UPREGULATION;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; INJECTIONS, INTRAPERITONEAL; ISCHEMIA; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MINERAL OIL; NF-KAPPA B; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 77951915635     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901889     Document Type: Article

References (84)

1. Einecke, G., M. Mengel, L. Hidalgo, K. Allanach, K. S. Famulski, and P. F. Halloran. 2009. The early course of kidney allograft rejection: defining the time when rejection begins. Am. J. Transplant. 9: 483-493.
2. Land, W. G. 2005. The role of postischemic reperfusion injury and other non-antigen-dependent inflammatory pathways in transplantation. Transplantation 79: 505-514.
3. Burne-Taney, M. J., N. Yokota, and H. Rabb. 2005. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int. 67: 1002-1009.
4. Takada, M., K. C. Nadeau, G. D. Shaw, K. A. Marquette, and N. L. Tilney. 1997. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99: 2682-2690.
5. Tanaka, M., G. K. Mokhtari, R. D. Terry, F. Gunawan, L. B. Balsam, G. Hoyt, K. H. Lee, P. S. Tsao, and R. C. Robbins. 2005. Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. J. Heart Lung Transplant. 24: 1906-1914.
6. Land, W. 2007. Innate alloimmunity: history and current knowledge. Exp. Clin. Transplant. 5: 575-584.
7. Chen, L., T. Wang, P. Zhou, L. Ma, D. Yin, J. Shen, L. Molinero, T. Nozaki, T. Phillips, S. Uematsu, et al. 2006. TLR engagement prevents transplantation tolerance. Am. J. Transplant. 6: 2282-2291.
8. Le Moine, A., and M. Goldman. 2003. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am. J. Transplant. 3: 101-106.
9. Alegre, M. L., S. Florquin, and M. Goldman. 2007. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr. Opin. Immunol. 19: 563-568.
10. Alegre, M. L., J. Leemans, A. Le Moine, S. Florquin, V. De Wilde, A. Chong, and M. Goldman. 2008. The multiple facets of Toll-like receptors in transplantation biology. Transplantation 86: 1-9.
11. Goldstein, D. R. 2004. Toll-like receptors and other links between innate and acquired alloimmunity. Curr. Opin. Immunol. 16: 538-544.
12. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
13. Goldstein, D. R., B. M. Tesar, S. Akira, and F. G. Lakkis. 2003. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111: 1571-1578.
14. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305. (Pubitemid 34303674)
15. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
16. Oyama, J., C. Blais, Jr., X. Liu, M. Pu, L. Kobzik, R. A. Kelly, and T. Bourcier. 2004. Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 109: 784-789. (Pubitemid 38222900)
17. Shen, X. D., B. Ke, Y. Zhai, F. Gao, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski. 2005. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am. J. Transplant. 5: 1793-1800.
18. Tang, S. C., T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 104: 13798-13803.
19. Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, and S. J. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117: 2847-2859.
20. Watson, M. J., B. Ke, X. D. Shen, F. Gao, R. W. Busuttil, J. W. Kupiec-Weglinski, and D. G. Farmer. 2008. Intestinal ischemia/reperfusion injury triggers activation of innate Toll-like receptor 4 and adaptive chemokine programs. Transplant. Proc. 40: 3339-3341.
21. Shigeoka, A. A., T. D. Holscher, A. J. King, F. W. Hall, W. B. Kiosses, P. S. Tobias, N. Mackman, and D. B. McKay. 2007. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178: 6252-6258.
22. Pulskens, W. P., G. J. Teske, L. M. Butter, J. J. Roelofs, T. van der Poll, S. Florquin, and J. C. Leemans. 2008. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One 3: e3596.
23. van der Woude, F. J., P. Schnuelle, and B. A. Yard. 2004. Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J. Investig. Med. 52: 323-329.
24. Zhang, W., M. Wang, H. Y. Xie, L. Zhou, X. Q. Meng, J. Shi, and S. Zheng. 2007. Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation. Transplant. Proc. 39: 1332-1337.
25. Ueno, T., K. Tanaka, M. Jurewicz, T. Murayama, I. Guleria, P. Fiorina, J. C. Paez, A. Augello, A. Vergani, M. Wong, et al. 2009. Divergent role of donor dendritic cells in rejection versus tolerance of allografts. J. Am. Soc. Nephrol. 20: 535-544.
26. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
27. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
28. Baratin, M., K. Bonin, and C. Daniel. 2004. Frontline: peripheral priming of alloreactive T cells by the direct pathway of allorecognition. Eur. J. Immunol. 34: 3305-3314.
29. Ochando, J. C., N. R. Krieger, and J. S. Bromberg. 2006. Direct versus indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization. Am. J. Transplant. 6: 2488-2496.
30. Kaliński, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20: 561-567.
31. + T cells. J. Immunol. 154: 5071-5079.
32. Strijdom, H., S. Genade, and A. Lochner. 2004. Nitric oxide synthase (NOS) does not contribute to simulated ischaemic preconditioning in an isolated rat cardiomyocyte model. Cardiovasc. Drugs Ther. 18: 99-112.
33. Meldrum, K. K., D. R. Meldrum, K. L. Hile, A. L. Burnett, and A. H. Harken. 2001. A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J. Surg. Res. 99: 288-293.
34. Lai, Z. F., and K. Nishi. 1998. Intracellular chloride activity increases in guinea pig ventricular muscle during simulated ischemia. Am. J. Physiol. 275: H1613-H1619.
35. Covington, M. D., K. J. Bayless, R. C. Burghardt, G. E. Davis, and A. R. Parrish. 2005. Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases. Am. J. Physiol. Renal Physiol. 289: F280-F288.
36. Patel, H. H., B. P. Head, H. N. Petersen, I. R. Niesman, D. Huang, G. J. Gross, P. A. Insel, and D. M. Roth. 2006. Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and δ-opioid receptors. Am. J. Physiol. Heart Circ. Physiol. 291: H344-H350.
37. Kishimoto, K., S. Sandner, J. Imitola, M. Sho, Y. Li, P. B. Langmuir, D. M. Rothstein, T. B. Strom, L. A. Turka, and M. H. Sayegh. 2002. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J. Clin. Invest. 109: 1471-1479.
38. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-a production by tristetraprolin. Science 281: 1001-1005. (Pubitemid 28399252)
39. Vial, D., L. Arbibe, N. Havet, C. Dumarey, B. Vargaftig, and L. Touqui. 1998. Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP. Biochem. J. 330: 89-94. (Pubitemid 28075726)
40. Seldon, P. M., P. J. Barnes, and M. A. Giembycz. 1998. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-a generation from human peripheral blood monocytes. Cell Biochem. Biophys. 29: 179-201.
41. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083.
42. Horn, F., C. Henze, and K. Heidrich. 2000. Interleukin-6 signal transduction and lymphocyte function. Immunobiology 202: 151-167. (Pubitemid 30642514)
43. Bleier, J. I., V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo. 2004. Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow. J. Immunol. 172: 7408-7416. (Pubitemid 38747602)
44. Shen, H., B. M. Tesar, W. E. Walker, and D. R. Goldstein. 2008. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J. Immunol. 181: 1849-1858.
45. Pan, K., H. Wang, W. L. Liu, H. K. Zhang, J. Zhou, J. J. Li, D. S. Weng, W. Huang, J. C. Sun, X. T. Liang, and J. C. Xia. 2009. The pivotal role of p38 and NF-κB signal pathways in the maturation of human monocyte-derived dendritic cells stimulated by streptococcal agent OK-432. Immunobiology 214: 350-358.
46. May, M. J., and S. Ghosh. 1998. Signal transduction through NF-κB. Immunol. Today 19: 80-88.
47. Paterson, H. M., T. J. Murphy, E. J. Purcell, O. Shelley, S. J. Kriynovich, E. Lien, J. A. Mannick, and J. A. Lederer. 2003. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J. Immunol. 171: 1473-1483.
48. Tsan, M. F., and B. Gao. 2004. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76: 514-519.
49. Tsung, A., N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar. 2007. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J. Leukoc. Biol. 81: 119-128.
50. Krüger, B., S. Krick, N. Dhillon, S. M. Lerner, S. Ames, J. S. Bromberg, M. Lin, L. Walsh, J. Vella, M. Fischereder, et al. 2009. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA 106: 3390-3395.
51. Bertho, N., H. Adamski, L. Toujas, M. Debove, J. Davoust, and V. Quillien. 2005. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction. Blood 106: 1734-1741.
52. Warncke, M., A. Dodero, H. Dierbach, M. Follo, and H. Veelken. 2006. Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses. J. Immunol. Methods 310: 1-11. (Pubitemid 43375970)
53. Lehner, M., P. Morhart, A. Stilper, D. Petermann, P. Weller, D. Stachel, and W. Holter. 2007. Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors. J. Immunother. 30: 312-322. (Pubitemid 46586647)
54. Goldstein, D. R. 2007. The identity of innate immune activators in organ transplantation: origins from within or exterior to the host? Am. J. Transplant. 7: 1692-1694.
55. Jang, H. R., and H. Rabb. 2009. The innate immune response in ischemic acute kidney injury. Clin. Immunol. 130: 41-50.
56. Perico, N., D. Cattaneo, M. H. Sayegh, and G. Remuzzi. 2004. Delayed graft function in kidney transplantation. Lancet 364: 1814-1827. (Pubitemid 39488068)
57. Lentine, K. L., D. C. Brennan, and M. A. Schnitzler. 2005. Incidence and predictors of myocardial infarction after kidney transplantation. J. Am. Soc. Nephrol. 16: 496-506.
58. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
59. Menges, M., S. Rössner, C. Voigtländer, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, and M. B. Lutz. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195: 15-21.
60. Witsch, E. J., M. Peiser, A. Hutloff, K. Büchner, B. G. Dorner, H. Jonuleit, H. W. Mages, and R. A. Kroczek. 2002. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Eur. J. Immunol. 32: 2680-2686.
61. Jonuleit, H., G. Adema, and E. Schmitt. 2003. Immune regulation by regulatory T cells: implications for transplantation. Transpl. Immunol. 11: 267-276.
62. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400. (Pubitemid 32673646)
63. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kämpgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184: 741-746.
64. Perona-Wright, G., S. J. Jenkins, R. A. O'Connor, D. Zienkiewicz, H. J. McSorley, R. M. Maizels, S. M. Anderton, and A. S. MacDonald. 2009. A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo. J. Immunol. 182: 2808-2815.
65. Dong, X., S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin. 2007. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71: 619-628.
66. Ridder, D. A., and M. Schwaninger. 2009. NF-κB signaling in cerebral ischemia. Neuroscience 158: 995-1006.
67. Cao, C. C., X. Q. Ding, Z. L. Ou, C. F. Liu, P. Li, L. Wang, and C. F. Zhu. 2004. In vivo transfection of NF-κB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 65: 834-845.
68. Kin, H., N. P. Wang, J. Mykytenko, J. Reeves, J. Deneve, R. Jiang, A. J. Zatta, R. A. Guyton, J. Vinten-Johansen, and Z. Q. Zhao. 2008. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-κB translocation and TNF α release. Shock 29: 761-768.
69. Liang, Y., K. Christopher, P. W. Finn, Y. L. Colson, and D. L. Perkins. 2007. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation 84: 771-777.
70. Grigoryev, D. N., M. Liu, H. T. Hassoun, C. Cheadle, K. C. Barnes, and H. Rabb. 2008. The local and systemic inflammatory transcriptome after acute kidney injury. J. Am. Soc. Nephrol. 19: 547-558.
71. de Vries, D. K., J. H. Lindeman, D. Tsikas, E. de Heer, A. Roos, J. W. de Fijter, A. G. Baranski, J. van Pelt, and A. F. Schaapherder. 2009. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am. J. Transplant. 9: 1574-1584.
72. + T cell regulatory functions. J. Immunol. 178: 271-279.
73. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
74. McKay, D., A. Shigeoka, M. Rubinstein, C. Surh, and J. Sprent. 2006. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur. J. Immunol. 36: 1994-2002.
75. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950.
76. Tesar, B. M., J. Zhang, Q. Li, and D. R. Goldstein. 2004. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a Toll-like receptor signal adaptor protein. Am. J. Transplant. 4: 1429-1439.
77. Beranek, J. T. 1997. Apoptosis is the main mechanism of cardiomyocyte death in the hyperacute rejection of heart xeno- and allografts. Transplantation 64: 1632-1633.
78. Buja, L. M., and M. L. Entman. 1998. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98: 1355-1357.
79. Daemen, M. A., C. van 't Veer, G. Denecker, V. H. Heemskerk, T. G. Wolfs, M. Clauss, P. Vandenabeele, and W. A. Buurman. 1999. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J. Clin. Invest. 104: 541-549.
80. Hassoun, H. T., M. L. Lie, D. N. Grigoryev, M. Liu, R. M. Tuder, and H. Rabb. 2009. Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis. Am. J. Physiol. Renal Physiol. 297: F125-F137.
81. Du, C., S. Wang, H. Diao, Q. Guan, R. Zhong, and A. M. Jevnikar. 2006. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury. Am. J. Transplant. 6: 2256-2267.
82. Mohib, K., Q. Guan, H. Diao, C. Du, and A. M. Jevnikar. 2007. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 293: F801-F812.
83. Ferlazzo, G., C. Semino, G. M. Spaggiari, M. Meta, M. C. Mingari, and G. Melioli. 2000. Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. Int. Immunol. 12: 1741-1747.
84. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89.